---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-22-000504"
form_type: "8-K"
ticker: "IMUX"
cik: "0001280776"
company_name: "IMMUNIC, INC."
filed_at: "2022-03-16T23:59:59+00:00"
generated_at: "2026-06-26T22:16:55.805648+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Immunic appoints Glenn Whaley as CFO and extends Executive Chairman Duane Nash's term to Dec 2022

## Summary
- Glenn Whaley appointed CFO effective March 10, 2022; received option grant for 40,000 shares (25% vest March 10, 2023, remainder monthly).
- Duane Nash's Executive Chairman agreement extended to December 31, 2022; base salary $29,358/month.
- Nash receives one-time option grant for 75,000 shares, vesting monthly from April 10, 2022.
- Both option exercise prices set at closing price on board approval date.

## SEC filing metadata
- accession: 0001193805-22-000504
- form_type: 8-K
- ticker: IMUX
- cik: 0001280776
- company_name: IMMUNIC, INC.
- filed_at: 2022-03-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1280776/000119380522000504/0001193805-22-000504-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1280776/000119380522000504/e621458_8k-immunic.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-22-000504
- JSON: https://secwatch.observer/filing/0001193805-22-000504.json
- Plain text: https://secwatch.observer/filing/0001193805-22-000504.txt

## Key facts
- Executive change
  Glenn Whaley was appointed as Chief Financial Officer at IMMUNIC, INC..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On March 10, 2022, Glenn Whaley was appointed Chief Financial Officer ("CFO") of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1280776/000119380522000504/0001193805-22-000504-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.